摘要:
6''-N-alkyl derivatives of kanamycin, 3'',4''-dideoxykanamycin B, 3'',4''-dideoxyneamine and 3'', 4''-dideoxyvistamycin, typically represented by 6''-N-methylkanamycin, 6''-N-methyl-3'',4''dideoxykanamycin B and 6''-N-methyl-3'', 4''-dideoxyvistamycin are synthetized by 6''-N-alkyltalation of the parent substances kanamycin, 3'',4''-dideoxykanamycin B, 3'',4''-dideoxynamine and 3'', 4''-dideoxyvistamycin and are new semi-synthetic antibiotics which are usefully active even against Escherichia and Pseudomonas species resistant to the parent substances.
摘要:
3''-DEOXYKANAMYCIN AS A NEW AND USEFUL KANAMYCIN DERIVATIVE WHICH IS EFFECTIVE EVEN AGAINST KANAMYCIN-RESISTANT STRAINS OF GRAMPOSITIVE AND GRAM-NEGATIVE BACTERIA, AND A PROCESS OF SYNTHETIZING 3''-DIOXYKANAMYCIN FROM KANAMYCIN.
摘要:
The 3''-hydroxyl group of neamine and related aminoglycosidic antibiotics is preferentially sulfonylated with an alkylsulfonyl halide, arylsulfonyl halide or benzylsulfonyl halide and the resultant 3''-sulfonic ester group halogenated with a concentrated solution of alkali metal bromide or iodide in an aprotic solvent to yield halogenated intermediates which can be hydrogenated to form corresponding 3''-deoxy derivatives which exhibit useful antibacterial activity even against bacteria resistant to the parent aminoglycosidic antibiotics.
摘要:
A new process of synthetizing an 1-N-((S)- Alpha -substitutedomega -aminoacyl) derivatives of aminoglycosidic antibiotic, including known compounds such as butirosin B as well as new compounds such as the derivatives of neamines and deoxyribostamycins, is provided according to this invention, in which process the initial aminoglycosidic antibiotic is poly-Nalkloxy- or -aralkyloxy- or aryloxy-carbonylated, the resulting poly-N-alkyloxy- or aralkyloxy- or aryloxy-carbonylated product is treated with a strong base such as sodium hydroxide or an alkali metal hydride to form the cyclic carbamate derivative according to new reactions and in which the cyclic carbamate derivative is treated with a weak base such as barium hydroxide to convert the 1-amino group of the antibiotic selectively into the free state while the other amino groups still remain in the protected condition. The 1-amino group of the antibiotic having the other amino groups protected is then acylated by reacting with the (S)- Alpha -substituted-107 -amino acid, and the acylation product is treated so as to remove the amino-protecting groups, giving the desired compound.